好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Retinopathy Due to Beta-Interferon Therapy in Multiple Sclerosis
MS and Related Diseases
(-)
076
Authors/Disclosures
Kirk Roberts, MD, FAAN (Columbia University Irving Medical Center/New York Presbyterian Hospital) Dr. Roberts has nothing to disclose.
Anja Thormann, MD, PhD (Bispebjerg Hospital) No disclosure on file
Elizabeth Donley, JD, MBA, MS (Stemina Biomarker Discovery) No disclosure on file
Peter Y. Kim, MD, PhD No disclosure on file
Per Solberg Sorensen, MD, PhD, FAAN (Rigshospitalet Glostrup) Dr. Sorensen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA.
No disclosure on file
Golnaz Moazami, MD (Columbia University Harkness Eye Institute) No disclosure on file
Nils Koch-Henriksen, MD (Dept of Neurology, Aalborg Hospital) Dr. Koch-Henriksen has nothing to disclose.
No disclosure on file
Julius Latorre, MD, FAAN (SUNY Upstate Med Univ Hosp/Neuro) Dr. Latorre has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Melinda Magyari, MD Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Magyari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Magyari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. The institution of Dr. Magyari has received research support from The Danish MS Society. The institution of Dr. Magyari has received research support from Biogen. The institution of Dr. Magyari has received research support from Novartis. The institution of Dr. Magyari has received research support from Roche. The institution of Dr. Magyari has received research support from Merck. The institution of Dr. Magyari has received research support from Sanofi.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file